Dusseldorf - Delayed Quote EUR
Akeso Inc (4RY.DU)
11.10
-0.10
(-0.89%)
At close: April 25 at 7:30:13 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
2,467,773
2,467,773
-1,240,413
-1,001,238
-617,775
Investing Cash Flow
-3,997,250
-3,997,250
-889,747
-579,585
-555,699
Financing Cash Flow
960,891
960,891
1,485,850
1,586,555
2,878,323
End Cash Position
1,542,313
1,542,313
2,092,388
2,641,625
2,684,499
Capital Expenditure
-879,490
-879,490
-802,498
-716,111
-448,470
Issuance of Capital Stock
--
--
500,466
992,028
2,714,530
Issuance of Debt
1,473,782
1,473,782
1,050,487
736,143
180,042
Repayment of Debt
-374,847
-374,847
-45,448
-90,760
-143,122
Repurchase of Capital Stock
--
--
--
-51,718
--
Free Cash Flow
1,588,283
1,588,283
-2,042,911
-1,717,349
-1,066,245
12/31/2020 - 4/27/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AKBLF ALK-Abelló A/S
19.90
0.00%
IVBXF Innovent Biologics, Inc.
5.98
0.00%
ZLDPF Zealand Pharma A/S
65.16
+1.02%
22UA.F BioNTech SE
87.65
-13.39%
ACLX Arcellx, Inc.
63.71
-0.41%
TIL Instil Bio, Inc.
12.78
-34.83%
MURA Mural Oncology plc
2.6000
-1.52%
RNA Avidity Biosciences, Inc.
30.84
-0.29%
SLXN Silexion Therapeutics Corp
0.9343
+0.46%
BCTX BriaCell Therapeutics Corp.
5.20
-13.76%